Europe Clinical Trials Support Services Market Forecast 2022-2030

The Europe clinical trials support services market is predicted to record a 7.96% CAGR over the estimation period, 2022 and 2030. Excellent patient recruitment rates and high-quality patient data accelerate market growth in the region.

MARKET INSIGHTS

The Europe clinical trials support services market growth assessment entails the evaluation of Germany, France, Denmark, Hungary, United Kingdom, Spain, Sweden, Italy, and Rest Of Europe. France's research and development sector are highly competitive in terms of skill levels and structure. France's regulatory approval process is quite slow, usually taking 236 days to complete. The main aim of the LEEM and the French government is to position France as the European leader in clinical research. Also, many key players in France offer clinical trial support services, driving their growth in France.

Recently, Italy has emerged as a key destination for global clinical trial programs, mostly focusing on medicines, knowledge, skills, and economic benefits. The Italian population has also started taking a keen interest in participating in clinical research. Additionally, there was an increase of 14% in global clinical trial participation compared to 2020.

On the other hand, in Sweden, clinical trials are important in developing new, appropriate medicinal products for humans and animals and medical devices and monitoring their use in healthcare. Pharmaceutical companies provide value to Swedish society through clinical trials. The positive economic effects of trials conducted in Sweden stem from various factors, including contributions to more and better healthcare, the creation of highly productive jobs, and drug cost savings.

COMPETITIVE INSIGHTS

Top players operating in the market entails KCR, ICON PLC, Alcura Health, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 47757

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING PREVALENCE OF CHRONIC DISEASE & VIRUS OUTBREAKS
- 3.1.2. BENEFITS OF CLINICAL TRIAL SUPPORT SERVICES
3.2. KEY RESTRAINTS
- 3.2.1. AVAILABILITY OF OPEN-SOURCE/FREEWARE SOFTWARE
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CLINICAL TRIALS SUPPORT SERVICES MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. PERFORMANCE
- 4.7.2. EASE OF USE
- 4.7.3. SECURITY
- 4.7.4. COST-EFFECTIVENESS
4.8. REGULATORY FRAMEWORK

5. MARKET BY PHASE

5.1. PHASE I
5.2. PHASE II
5.3. PHASE III
5.4. PHASE IV

6. MARKET BY SPONSOR

6.1. PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES
6.2. MEDICAL DEVICE COMPANIES
6.3. OTHER SPONSORS

7. MARKET BY SERVICE

7.1. CLINICAL TRIAL SITE MANAGEMENT
7.2. ADMINISTRATIVE STAFF
7.3. PATIENT RECRUITMENT MANAGEMENT
- 7.3.1. PATIENT RECRUITMENT & REGISTRY SERVICES
- 7.3.2. PATIENT RETENTION
- 7.3.3. OTHER PATIENT RECRUITMENT MANAGEMENT
7.4. IRB
7.5. DATA MANAGEMENT
7.6. OTHER SERVICES

8. GEOGRAPHICAL ANALYSIS

8.1. EUROPE
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. KEY GROWTH ENABLERS
- 8.1.3. KEY CHALLENGES
- 8.1.4. KEY PLAYERS
- 8.1.5. COUNTRY ANALYSIS
  - 8.1.5.1. UNITED KINGDOM
  - 8.1.5.2. GERMANY
  - 8.1.5.3. FRANCE
  - 8.1.5.4. SPAIN
  - 8.1.5.5. ITALY
  - 8.1.5.6. SWEDEN
  - 8.1.5.7. DENMARK
  - 8.1.5.8. HUNGARY
  - 8.1.5.9. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ADVANCED CLINICAL
- 9.2.2. ALCURA
- 9.2.3. CHARLES RIVER LABORATORIES INC
- 9.2.4. CLINIPACE
- 9.2.5. CTI CLINICAL TRIAL AND CONSULTING SERVICES INC
- 9.2.6. ICON PLC
- 9.2.7. IQVIA
- 9.2.8. KCR
- 9.2.9. LABCORP DRUG DEVELOPMENT
- 9.2.10. MEDPACE
- 9.2.11. PAREXEL
- 9.2.12. PSI CRO
- 9.2.13. SYNEOS HEALTH
- 9.2.14. WORLDWIDE CLINICAL TRIALS
- 9.2.15. WUXI APPTEC

Product Code: 47757

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CLINICAL TRIALS SUPPORT SERVICES
TABLE 2: LIST OF PANDEMIC OUTBREAKS
TABLE 3: LIST OF OPEN-SOURCE SOFTWARE
TABLE 4: LIST OF PARTNERSHIPS
TABLE 5: LAUNCH OF MEDICAL DRUGS
TABLE 6: PROMISING ACQUISITIONS IN THE INDUSTRY
TABLE 7: REGULATORY FRAMEWORK
TABLE 8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SPONSOR, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY SERVICE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
TABLE 17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
TABLE 18: LEADING PLAYERS OPERATING IN EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET
TABLE 19: LIST OF MERGERS & ACQUISITIONS
TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 22: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PHASE, IN 2021
FIGURE 8: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE I, 2022-2030 (IN $ MILLION)
FIGURE 9: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE II, 2022-2030 (IN $ MILLION)
FIGURE 10: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE III, 2022-2030 (IN $ MILLION)
FIGURE 11: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHASE IV, 2022-2030 (IN $ MILLION)
FIGURE 12: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SPONSOR, IN 2021
FIGURE 13: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 14: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY MEDICAL DEVICE COMPANIES, 2022-2030 (IN $ MILLION)
FIGURE 15: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SPONSORS, 2022-2030 (IN $ MILLION)
FIGURE 16: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY SERVICE, IN 2021
FIGURE 17: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY CLINICAL TRIAL SITE MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 18: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY ADMINISTRATIVE STAFF, 2022-2030 (IN $ MILLION)
FIGURE 19: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 20: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, GROWTH POTENTIAL, BY PATIENT RECRUITMENT MANAGEMENT, IN 2021
FIGURE 21: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RECRUITMENT & REGISTRY SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 22: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY PATIENT RETENTION, 2022-2030 (IN $ MILLION)
FIGURE 23: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER PATIENT RECRUITMENT MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 24: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY IRB, 2022-2030 (IN $ MILLION)
FIGURE 25: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY DATA MANAGEMENT, 2022-2030 (IN $ MILLION)
FIGURE 26: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, BY OTHER SERVICES, 2022-2030 (IN $ MILLION)
FIGURE 27: EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
FIGURE 28: UNITED KINGDOM CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 29: GERMANY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 30: FRANCE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 31: SPAIN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 32: ITALY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 33: SWEDEN CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 34: DENMARK CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 35: HUNGARY CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)
FIGURE 36: REST OF EUROPE CLINICAL TRIALS SUPPORT SERVICES MARKET, 2022-2030 (IN $ MILLION)